STRENGTHENSNCT07818889
Study to Refine the Effectiveness of New Generation Therapies for Suicide
At risk: Primary endpoint(s) modified.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary endpoint(s) modified
- Eligibility criteria expanded, about 1 word
- Secondary endpoints: 1 to 2
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (2)
Arms and interventions
Participants will complete reasons for living in session 2, physiological regulation in session 3, and sleep in session 4.
Sleep in session 2, physiological regulation in session 3, and reasons for living in session 4.
Beginning at week 4, participants will be classified as treatment responders if they (1) have not engaged in any preparatory behavior or made any suicide attempts (aborted, interrupted, or actual) and (2) have an SCS-R total score ≤21. Participants who do not meet these criteria will continue BCBT and be randomized a second time to determine if cognitive reappraisal or behavioral activation components are delivered next (sessions 5-9).
Beginning at week 4, participants will be classified as treatment responders if they (1) have not engaged in any preparatory behavior or made any suicide attempts (aborted, interrupted, or actual) and (2) have an SCS-R total score ≤21. Participants who do not meet these criteria will continue BCBT and be randomized a second time to determine if cognitive reappraisal or behavioral activation components are delivered next (sessions 5-9).
Behavioral: Brief Cognitive Behavioral Therapy
Sites
1 site in 1 country
- Department of Psychiatry and Behavioral HealthColumbus, Ohio, United States